Navigation Links
Beckman Coulter Announces First Quarter 2008 Results
Date:4/30/2008

ir market value inventory adjustment -- In connection with our

acquisition of the flow cytometry business of Dako A/S, we recorded a

$1.0 million charge related to the fair value of acquired inventory

sold in the first quarter.

BECKMAN COULTER, INC.

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS

(in millions, except amounts per share and share data)

(unaudited)

Three Months Ended

March 31,

2008 2007

Product revenue $618.3 $512.4

Service revenue 112.2 101.2

Total revenue 730.5 613.6

Cost of goods sold 308.2 243.8

Cost of service 87.0 72.4

Total cost of sales 395.2 316.2

Gross profit 335.3 297.4

Operating costs and expenses

Selling, general and administrative 203.6 175.4

Research and development 62.7 57.8

Restructuring 0.7 6.9

Total operating costs and expenses 267.0 240.1

Operating income 68.3 57.3

Non-operating (income) expense

Interest income (2.6) (4.6)

Interest expense 9.0 12.4

Other, net 5.2 2.2

Total non-operating expe
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related biology technology :

1. Beckman Coulter Acquires Rights to Hepatitis C Virus
2. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
3. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
4. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
5. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell
6. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
7. Beckman Coulter to Present at the JPMorgan Healthcare Conference
8. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
9. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
10. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
11. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...ter and Houston-based Proximity Systems ... Oct. 13 /- One year after installing...erpoint Medical Center offers,favorable reviews an...retractable computer workstations are satisfying t...ients, IT department and designers., When Nashvil...
(Date:10/13/2008)...HA, Wisconsin, October 13 /-,Radi Med...a development;,marketing and sales initiative to i...king wireless PressureWire(R) Aeris and Fractional...) IT hemodynamic recording system., This agreemen...ng,together GE,s proven Mac-Lab IT with first of i...
(Date:10/13/2008).../Xinhua-- China Medicine,Corporation ...e Company"),a leading distributor and developer o...s, traditional Chinese medicines ("TCM"), nutritio...medical formulations in the,People,s Republic of C...ary, Konzern U.S Holding Corporation, announced to...
(Date:10/13/2008)...understanding of individual risk of basal,cell car...ersonal genome,analysis scan, REYKJAVIK, Iceland,...eCODE genetics (Nasdaq: DCGN ) today report the d...ariations in the human genome (SNPs) that,confer r... cancer among,people of European ancestry. Unlike ...
Breaking Biology Technology:In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 2In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 3In-Room Computers and Wall-Mounted Proximity Systems Computer WorkStations Deliver Increased Efficiency; Improved Patient Care 4Radi Medical Systems AB and GE Healthcare Announce Cooperation to Integrate FFR and PressureWire(R) Aeris in GE Mac-Lab(R) IT 2Radi Medical Systems AB and GE Healthcare Announce Cooperation to Integrate FFR and PressureWire(R) Aeris in GE Mac-Lab(R) IT 3China Medicine to Showcase 'Bethin' Weight Loss Product at 2008 Natural Products Expo East Trade Show 2China Medicine to Showcase 'Bethin' Weight Loss Product at 2008 Natural Products Expo East Trade Show 3deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 2deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 3deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer 4
...he business section of Sunday,s San Jose Mercury N...ff 35% ." , ,After several quarters of increasing ...illion into new businesses last quarter, down a th...ding to the MoneyTree Survey conducted by Pricewat...National Venture Capital Association. While a 35% ...
...dison, Wis. Governor Jim Doyle announced today o...r the state to maintain its leadership in the fiel...l research. The governor said that almost $750 mil...eral years, and he outlined a series of investment...ry on the UW-Madison campus. , Read the latest...
...he other day I went to a lecture on angel investin...ience raised his hand. He wanted to know whether t...s from Fond du Lac to Green Bay had enough entrep...nvestors. , ,When I heard this, I realized that th...nsins perception of itself. A number of Wisconsin-...
...or years, our firm has been touting the Bureau of ...oyees will leave the workforce for every new one e...e of ten million employees. , ,In an election cycl...ff-shoring is becoming de rigueur, these numbers s...st common arguments I hear refuting BLS statistics...
Other Biology Technology:Start-ups grow up 2Start-ups grow up 3Wisconsins governor unveils $750 million investment for stem cell and health research 2Wisconsin entrepreneurs need to self-promote like coastal rivals 2Wisconsin entrepreneurs need to self-promote like coastal rivals 3Wisconsin entrepreneurs need to self-promote like coastal rivals 4Wisconsin entrepreneurs need to self-promote like coastal rivals 5Wisconsin entrepreneurs need to self-promote like coastal rivals 6Talent shortage? Cmon. 2
(Date:10/10/2008)... in German . , DNA, the molecule that acts as...f life, is highly resistant against alteration by ... for its photostability presents some puzzling pro... four chemical bases that make up the DNA molecule... showing that DNA strands differ in their light se...
(Date:10/9/2008).... 9 /PRNewswire-FirstCall/ -- Synaptics(R),Incorpo...an interface,solutions for mobile computing, commu...day that it will report financial results for the ...23, 2008 after the close of market. The,company wi...ts and,investors at 2:00 p.m. PT (5:00 p.m. ET) du...
(Date:10/9/2008)...ed life,s ability to respond? Biodiversity in a Wa...f the journal, Science , illustrates that cross-d...ropical Research Institute in Panama clearly infor...region of rainforest and coral reefs, the tropics ...rming. Some disagree, arguing that tropical organi...
(Date:10/9/2008)...years, the number of patients with compromised imm...tients such as these require a unique set of healt...thing from the etiology and degree of immune suppr...tus. A new text from ASM Press, Diagnostic Microbi...ide range of approaches and challenges to infectio...
Breaking Biology News(10 mins):Can genetic information be controlled by light? 2Synaptics to Report First Quarter Results on October 23 2Smithsonian perspective: Biodiversity in a warmer world 2Text focuses on diagnosing infections in immunocompromised patients 2Threshold for bowel surgery may be too high warn experts 5076 1Threshold for bowel surgery may be too high warn experts 5076 2MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 5073 1MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 5073 2MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 5073 3MAP Pharmaceuticals Initiates Phase 2a Clinical Trial of Combination Therapy in Adult Patients with Asthma 5073 4Anesiva Announces Upcoming Webcasts and Conference Participation 5068 1Anesiva Announces Upcoming Webcasts and Conference Participation 5068 2King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 1King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 2King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 3King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 4King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 5King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acuras Aversion 5063 6
...trospective study in the Canadian Medical Associat...ularly boys, are about twice as likely as the tota...m an injury. , Brison and colleagues collected and...ries to young children to determine rates, identif...ms and ranches. They found that children 1? years ...
...e compounds could be a key component for cheaper, ...a Richards in Chemistry & Industry magazine. ,...each year, of which nearly 2,700 die, according to...ut is unsuitable for most patients, and liver tumo...an Cancer Society estimates that 18,510 new cases ...
...ers have found that the neurotransmitter serotonin...promote lasting, quality sleep in an animal model ...ntral to the lives of most animals, the proper reg... , The findings are reported by Quan Yuan, Willia...nnsylvania, and appear in the June 6th issue of Cu...
...e lovers, beware. Each year 20 percent of the caca...o plant diseases, but even greater losses would oc...eases are the most important constraints to cacao ...d,s confectionary trades," said Randy Ploetz, plan..., Homestead, FL. Currently, 4 million metric tons ...
Other Biology News:
Highly nutritious peptone, used in media for the production of bacterial toxins, and for the cultivation of bacteria with high nutritional requirements e.g Corynbacterium, Haemophilus, Neisseria, Pas
...ls were cultured in RPMI 1640 medium with 2 mM L-g... In order to keep the antigens in their native fo...lls are arrayed on a 12-well (5 mm) adhesive coate...ted to enhance cellular attachment and to minimize...
...s were cultured in Minimum Essential Medium (Eagle...hase of growth. In order to keep the antigens in ...thanol. The cells are arrayed on a 12-well (5 mm)...ecifically treated to enhance cellular attachment ...
CELLine System cultivation flask (for secreted products)
Biology Products: